MORC2 and neuroblastoma: Here, to evaluate the pathogenicity of MORC2 variants of unknown significance, we have developed an in vitro system based on the overexpression of wild‐type (WT) or mutant MORC2 proteins in a neuroblastoma cell line SH‐EP and in primary cortical neurons.